Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study: an Ambispective, Multicentre, Open Cohort Study

NCT03401619 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT03401619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study: an Ambispective, Multicentre, Open Cohort Study
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 21, 2017
Completion date
September 22, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis，neurological disorders